Gabelli Funds’s Eli Lilly LLY Stock Holding History

Gabelli Funds’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$96.1M	Buy	104,478 +144	+0.1%	+$146K	0.65%	24
2025 Q4	$112M	Buy	104,334 +62	+0.1%	+$59.3K	0.76%	21
2025 Q3	$79.6M	Buy	104,272 +590	+0.6%	+$439K	0.54%	35
2025 Q2	$80.8M	Sell	103,682 -307	-0.3%	-$239K	0.57%	29
2025 Q1	$85.9M	Sell	103,989 -15,018	-13%	-$12.5M	0.65%	25
2024 Q4	$91.9M	Sell	119,007 -2,183	-2%	-$1.81M	0.69%	27
2024 Q3	$107M	Sell	121,190 -1,058	-0.9%	-$951K	0.77%	22
2024 Q2	$111M	Sell	122,248 -5,306	-4%	-$4.24M	0.84%	20
2024 Q1	$99.2M	Buy	127,554 +698	+0.6%	+$497K	0.73%	21
2023 Q4	$73.9M	Buy	126,856 +23,135	+22%	+$13.5M	0.57%	32
2023 Q3	$55.7M	Sell	103,721 -8,330	-7%	-$4.29M	0.45%	50
2023 Q2	$52.5M	Buy	112,051 +20,640	+23%	+$8.66M	0.4%	55
2023 Q1	$31.4M	Buy	91,411 +72	+0.1%	+$24.3K	0.24%	112
2022 Q4	$33.4M	Buy	91,339 +41,939	+85%	+$14.9M	0.26%	102
2022 Q3	$16M	Sell	49,400 -800	-2%	-$253K	0.13%	213
2022 Q2	$16.3M	Sell	50,200 -5,760	-10%	-$1.73M	0.13%	229
2022 Q1	$16M	Hold	55,960	–	–	0.11%	256
2021 Q4	$15.5M	Hold	55,960	–	–	0.1%	264
2021 Q3	$12.9M	Sell	55,960 -2,000	-3%	-$494K	0.09%	290
2021 Q2	$13.3M	Sell	57,960 -2,000	-3%	-$402K	0.08%	302
2021 Q1	$11.2M	Hold	59,960	–	–	0.08%	323
2020 Q4	$10.1M	Hold	59,960	–	–	0.07%	326
2020 Q3	$8.88M	Sell	59,960 -12,000	-17%	-$1.86M	0.07%	324
2020 Q2	$11.8M	Sell	71,960 -1,000	-1%	-$153K	0.1%	273
2020 Q1	$10.1M	Hold	72,960	–	–	0.09%	273
2019 Q4	$9.59M	Sell	72,960 -3,500	-5%	-$406K	0.06%	356
2019 Q3	$8.55M	Sell	76,460 -6,938	-8%	-$772K	0.06%	378
2019 Q2	$9.24M	Hold	83,398	–	–	0.06%	362
2019 Q1	$10.8M	Sell	83,398 -63,702	-43%	-$7.75M	0.07%	349
2018 Q4	$17M	Sell	147,100 -41,500	-22%	-$4.64M	0.12%	239
2018 Q3	$20.2M	Sell	188,600 -27,500	-13%	-$2.75M	0.12%	247
2018 Q2	$18.4M	Sell	216,100 -16,900	-7%	-$1.39M	0.11%	263
2018 Q1	$18M	Sell	233,000 -7,000	-3%	-$564K	0.11%	269
2017 Q4	$20.3M	Sell	240,000 -74,000	-24%	-$6.3M	0.12%	255
2017 Q3	$26.9M	Sell	314,000 -13,000	-4%	-$1.07M	0.15%	193
2017 Q2	$26.9M	Sell	327,000 -25,000	-7%	-$2.04M	0.16%	191
2017 Q1	$29.6M	Sell	352,000 -53,000	-13%	-$4.25M	0.17%	181
2016 Q4	$29.8M	Sell	405,000 -123,000	-23%	-$9.16M	0.18%	181
2016 Q3	$42.4M	Sell	528,000 -22,000	-4%	-$1.76M	0.25%	114
2016 Q2	$43.3M	Sell	550,000 -32,000	-5%	-$2.41M	0.26%	109
2016 Q1	$41.9M	Sell	582,000 -44,000	-7%	-$3.33M	0.25%	113
2015 Q4	$52.7M	Buy	626,000 +15,000	+2%	+$1.24M	0.32%	85
2015 Q3	$51.1M	Hold	611,000	–	–	0.3%	91
2015 Q2	$51M	Hold	611,000	–	–	0.27%	112
2015 Q1	$44.4M	Sell	611,000 -2,000	-0.3%	-$142K	0.23%	133
2014 Q4	$42.3M	Hold	613,000	–	–	0.21%	149
2014 Q3	$39.8M	Hold	613,000	–	–	0.2%	150
2014 Q2	$38.1M	Sell	613,000 -5,000	-0.8%	-$298K	0.19%	160
2014 Q1	$36.4M	Hold	618,000	–	–	0.19%	164
2013 Q4	$31.5M	Sell	618,000 -5,000	-0.8%	-$250K	0.17%	185
2013 Q3	$31.4M	Sell	623,000 -3,000	-0.5%	-$157K	0.18%	173
2013 Q2	$30.7M	Buy	+626,000	New	+$34.1M	0.19%	170

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Gabelli Funds's LLY Position: Q1 2026 in Review

Gabelli Funds increased its Eli Lilly (LLY) stake by 0.14% in Q1 2026, buying an estimated $146K and bringing the position to 104,478 shares worth $96.1M. The position accounts for 0.65% of the portfolio, ranked #24.

Gabelli Funds first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $112M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Gabelli Funds held 104,478 shares of Eli Lilly worth $96.1M as of Q1 2026.
Gabelli Funds bought 144 Eli Lilly shares in Q1 2026, an estimated $146K.
Eli Lilly made up 0.65% of Gabelli Funds's portfolio in Q1 2026, its #24 holding.
Gabelli Funds first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
Gabelli Funds's Eli Lilly position peaked at $112M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.